Table 1. Intracellular miRNA DR biomarkers.
Disorder | miRNA | Tissue | Targets | Action | Reference |
---|---|---|---|---|---|
DR | miR-21 | Endothelial cells | Endothelial cells dysfunction; | Pathogenic, inflammation | (19) |
DR | miR-216a | Rat retina, HRMECs | Suppression of NOS2/JAK/STAT | Protections of HRMECs | (20) |
DR | miR-29b-3p | HRMEC | Blocking SIRT1 | Pathogenic, HRMEC apoptosis | (21) |
PDR | miR-203a-3p | Rat retina, OIR | VEGFA, HIF-1α | Inhibits angiogenesis | (22) |
DR | miR-183 | Rat retina | PI3K/Akt/VEGF, upregulating BTG1 | Silencing inhibits cells growth | (22) |
DR | miR-200b | Diabetic mouse retina, RMECs | VEGF | Inhibits VEGF | (23,24) |
DR, diabetic retinopathy; PDR, proliferative diabetic retinopathy; miR, microRNA; HRMEC, Human Retinal Microvascular Endothelial Cells; RMECs, Retinal Microvascular Endothelial Cells; OIR, oxygen-induced retinopathy; NOS2/JAK/STAT, Nitric Oxide Synthase 2/Janus Kinase/Signal Transducer and Activator of Transcription; SIRT1, sirtuin 1; VEGF, vascular endothelial growth factor; HIF-1α, Hypoxia-inducible factor 1-α; PI3K/Akt, Phosphatidylinositol 3-kinase/Akt, Protein Kinase B; BTG1, B-Cell Translocation Gene 1 Protein.